Shanghai, China · Founded 2016 · Privately Held (backing)
Manufacturer of innovative anti-cancer drugs based in Shanghai, China. EnnovaBio is based in Shanghai, China and was founded in 2016. It has raised $24.2 million.
Last price · $/share
—
Implied valuation
—
Total raised
$24.2M
Last round
—
Cap table — not yet on record
EnnovaBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EnnovaBio with a free account
·Watch EnnovaBio: the Monday email on marks, rounds and moves
